Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
Main Author: | Frontiers Editorial Office |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Oncology |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1298871/full |
Similar Items
-
Significance of microRNA-targeted ErbB signaling pathway genes in cardiomyocyte differentiation
by: Akram Gholipour, et al.
Published: (2023-06-01) -
Retraction: PRDM16 upregulation induced by MicroRNA-448 inhibition alleviates atherosclerosis via the TGF-β signaling pathway inactivation
by: Frontiers Editorial Office
Published: (2023-10-01) -
Investigation of ErbB and Insulin Signaling Pathways in the Pathogenesis of Multiple Myeloma
by: Derya Öztürk, et al.
Published: (2018-06-01) -
Retraction: Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging microRNA-760 and upregulating hepatoma-derived growth factor
by: Frontiers Editorial Office
Published: (2023-01-01) -
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020-06-01)